94 related articles for article (PubMed ID: 26851012)
1. α-Bisabolol Inhibits Invasiveness and Motility in Pancreatic Cancer Through KISS1R Activation.
Uno M; Kokuryo T; Yokoyama Y; Senga T; Nagino M
Anticancer Res; 2016 Feb; 36(2):583-9. PubMed ID: 26851012
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of α-bisabolol against pancreatic cancer.
Seki T; Kokuryo T; Yokoyama Y; Suzuki H; Itatsu K; Nakagawa A; Mizutani T; Miyake T; Uno M; Yamauchi K; Nagino M
Cancer Sci; 2011 Dec; 102(12):2199-205. PubMed ID: 21883695
[TBL] [Abstract][Full Text] [Related]
3. The Anticancer Effects of Novel α-Bisabolol Derivatives Against Pancreatic Cancer.
Murata Y; Kokuryo T; Yokoyama Y; Yamaguchi J; Miwa T; Shibuya M; Yamamoto Y; Nagino M
Anticancer Res; 2017 Feb; 37(2):589-598. PubMed ID: 28179305
[TBL] [Abstract][Full Text] [Related]
4. Lack of KISS1R expression is associated with rapid progression of conventional renal cell carcinomas.
Chen Y; Yusenko MV; Kovacs G
J Pathol; 2011 Jan; 223(1):46-53. PubMed ID: 20922711
[TBL] [Abstract][Full Text] [Related]
5. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.
Cvetkovic D; Dragan M; Leith SJ; Mir ZM; Leong HS; Pampillo M; Lewis JD; Babwah AV; Bhattacharya M
Endocrinology; 2013 Jun; 154(6):1999-2014. PubMed ID: 23525242
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan stimulates pancreatic cancer cell motility.
Cheng XB; Kohi S; Koga A; Hirata K; Sato N
Oncotarget; 2016 Jan; 7(4):4829-40. PubMed ID: 26684359
[TBL] [Abstract][Full Text] [Related]
7. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer.
Hiroshima Y; Nakamura F; Miyamoto H; Mori R; Taniguchi K; Matsuyama R; Akiyama H; Tanaka K; Ichikawa Y; Kato S; Kobayashi N; Kubota K; Nagashima Y; Goshima Y; Endo I
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S369-78. PubMed ID: 22805864
[TBL] [Abstract][Full Text] [Related]
8. X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, MIAPaCa-2, which exhibits mesenchymal and amoeboid motility.
Fujita M; Otsuka Y; Yamada S; Iwakawa M; Imai T
Cancer Sci; 2011 Apr; 102(4):792-8. PubMed ID: 21214671
[TBL] [Abstract][Full Text] [Related]
9. Involvement of annexin A8 in the properties of pancreatic cancer.
Hata H; Tatemichi M; Nakadate T
Mol Carcinog; 2014 Mar; 53(3):181-91. PubMed ID: 23001853
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene.
Ohuchida K; Mizumoto K; Lin C; Yamaguchi H; Ohtsuka T; Sato N; Toma H; Nakamura M; Nagai E; Hashizume M; Tanaka M
Ann Surg Oncol; 2012 Jul; 19(7):2394-402. PubMed ID: 22407312
[TBL] [Abstract][Full Text] [Related]
11. The sesquiterpene α-bisabolol in the adipocyte-cancer desmoplastic crosstalk: does it have an action on epithelial-mesenchymal transition mechanisms?
Chirumbolo S; Bjørklund G
Int J Clin Oncol; 2017 Apr; 22(2):222-228. PubMed ID: 27942879
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin Conjugated α-Bisabolol Suppresses FAK Phosphorylation and Induces Apoptosis in Pancreatic Cancer.
Kano MT; Kokuryo T; Baba T; Yamazaki K; Yamaguchi J; Sunagawa M; Ogura A; Watanabe N; Onoe S; Miyata K; Mizuno T; Uehara K; Igami T; Yokoyama Y; Ebata T; Nagino M
Anticancer Res; 2023 Mar; 43(3):1009-1016. PubMed ID: 36854520
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophic artemin promotes motility and invasiveness of MIA PaCa-2 pancreatic cancer cells.
Meng LX; Chi YH; Wang XX; Ding ZJ; Fei LC; Zhang H; Mou L; Cui W; Xue YJ
Asian Pac J Cancer Prev; 2012; 13(5):1793-7. PubMed ID: 22901124
[TBL] [Abstract][Full Text] [Related]
14. Alpha-bisabolol Promotes Glioma Cell Death by Modulating the Adenosinergic System.
Mendes FB; Bergamin LS; Dos Santos Stuepp C; Braganhol E; Terroso T; Pohlmann AR; Guterres SS; Battastini AM
Anticancer Res; 2017 Apr; 37(4):1819-1823. PubMed ID: 28373446
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
16. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cells.
Vanova K; Boukalova S; Gbelcova H; Muchova L; Neuzil J; Gurlich R; Ruml T; Vitek L
BMC Cancer; 2016 May; 16():309. PubMed ID: 27175805
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
Kim SO; Kim MR
Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
[TBL] [Abstract][Full Text] [Related]
20. Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth.
Takahashi N; Fukushima T; Yorita K; Tanaka H; Chijiiwa K; Kataoka H
Int J Cancer; 2010 Apr; 126(7):1611-20. PubMed ID: 19711349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
